Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2010
02/25/2010US20100047788 Method and kit for diagnosis and monitoring of the treatment of chronic tripanossomiasis and chagas disease
02/25/2010US20100047787 Prostate cancer survival and recurrence
02/25/2010US20100047786 DNA-based test for detection of annual and intermediate ryegrass
02/25/2010US20100047785 Pkd mutations and evaluation of same
02/25/2010US20100047784 Method for detecting nucleic acids
02/25/2010US20100047783 Small molecule modulators of p53 family signaling
02/25/2010US20100047782 Assessment of risk for colorectal cancer
02/25/2010US20100047781 Primer set for detection of dekkera yeast or brettanomyces yeast
02/25/2010US20100047780 Target and method for inhibition of bacterial rna polymerase
02/25/2010US20100047779 Biomarkers
02/25/2010US20100047778 Methylation Specific Primer Extension Assay for the Detection of Genomic Imprinting Disorders
02/25/2010US20100047777 Methods for identifying mutations in coding and non-coding dna
02/25/2010US20100047776 Cell-based screening assays for compounds that regulate the expresion of a tumor marker dj-1
02/25/2010US20100047775 Method of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding
02/25/2010US20100047774 Cartridge, system and method for automated medical diagnostics
02/25/2010US20100047773 Novel circle probes and their use in the identification of biomolecules
02/25/2010US20100047772 Compounds, compositions and methods for the treatment of diseases characterized by a-33 related antigens
02/25/2010US20100047771 Markers for the diagnosis of lung cancer
02/25/2010US20100047770 Detection of Breast Cancer
02/25/2010US20100047769 having controlling effects on growth and differentiation of undifferentiated cells; can affect stem cells to trigger the growth arrest signal; inhibits a SELF promoter activity
02/25/2010US20100047768 Amplification of single viral genomes
02/25/2010US20100047767 Pathogen binding
02/25/2010US20100047766 Analyte manipulation and detection
02/25/2010US20100047765 Molecular determinants associated with enhanced ability to enter cells expressing cxcr4
02/25/2010US20100047764 Novel surface protein (HBsAg) variant of the hepatitis B virus
02/25/2010US20100047763 Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes
02/25/2010US20100047762 Method to monitor drug efficacy in diabetic patients using an assay for 1,5-anhydro-d-glucitol
02/25/2010US20100047392 Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them
02/25/2010US20100047368 Compositions and methods for the treatment or prevention of chemoresistant neoplasia
02/25/2010US20100047281 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
02/25/2010US20100047278 Human Rotavirus and Vaccine Composition Comprising Same
02/25/2010US20100047277 Virosomes, methods of preparation, and immunogenic compositions
02/25/2010US20100047273 Coxsackie B virus and type 1 diabetes
02/25/2010US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
02/25/2010US20100047240 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
02/25/2010US20100047222 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof
02/25/2010US20100047177 treating or preventing axonal degradation in neuropathic diseases in mammals; axonopathy; administering an agent that increases AMP activated kinase (AMPK), LKB1 and CaMKK beta acitvity in diseased and/or injured neurons and supporting cells in an amount effective to decrease axonal degeneration
02/25/2010US20100047172 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
02/25/2010US20100047166 Antibodies and related molecules that bind to 58p1d12 proteins
02/25/2010US20100045977 Methods of Analyzing Samples Using Broadband Laser Light
02/25/2010DE102008062965A1 System, useful e.g. to produce a medicament to treat malignant diseases and metastatic tumors and for the isolation of a specific element of a molecular library, comprises a reaction chamber partitioned into a number of compartments
02/25/2010CA2735677A1 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
02/25/2010CA2734783A1 Method for chromogenic detection of two or more target molecules in a single sample
02/25/2010CA2734514A1 Self-avoiding molecular recognition systems in dna amplification
02/25/2010CA2734428A1 Susceptibility to hsp90-inhibitors
02/25/2010CA2734121A1 Enhancing endotoxin detection
02/25/2010CA2733765A1 Halo-hydrocarbon polymer coating
02/25/2010CA2733718A1 Methods for determining a breeding value based on a plurality of genetic markers
02/25/2010CA2732783A1 Methods for removal of specific seed tissue or structure for seed analysis
02/25/2010CA2732684A1 Method and system for data driven management of individual seeds
02/25/2010CA2732493A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof
02/25/2010CA2729563A1 Genetic loci associated with head smut resistance in maize
02/24/2010EP2157524A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
02/24/2010EP2157192A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins)
02/24/2010EP2157191A2 Method and nucleic acids for the improved treatment of breast cell proliferative disorders
02/24/2010EP2157190A1 Method of measuring the activity of lipid-modified enzyme
02/24/2010EP2157189A1 Apparatus and method for performing cellularsusceptibility testing
02/24/2010EP2157180A2 Method for amplifying specific nucleic acid fragments with the aid of a recurrent chain reaction
02/24/2010EP2157166A1 Model cell chip, apparatus for evaluating drug effect using the model cell chip and method of evaluating drug effect
02/24/2010EP2157092A1 Remedy for diabetes
02/24/2010EP2156892A2 Improvements in thermal cycler for PCR
02/24/2010EP2156891A2 System and method for incubating the contents of a reaction receptacle
02/24/2010EP2156830A1 Modulators of asparaginyl hydoxylase activity of FIH
02/24/2010EP2156376A1 Methods for counting cells
02/24/2010EP2156179A1 Compositions, devices, systems, and methods for using a nanopore
02/24/2010EP2155913A1 Method for determining the effects of external stimuli on biological pathways in living cells
02/24/2010EP2155912A2 Primers and probes for the detection of streptococcus pneumoniae
02/24/2010EP2155911A1 Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
02/24/2010EP2155910A1 Compositions and methods for characterizing and regulating olfactory sensation
02/24/2010EP2155909A2 A novel method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system
02/24/2010EP2155908A1 Germline polymorphisms in the angiogenic pathway predict tumor recurrence in cancer therapy
02/24/2010EP2155907A2 Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
02/24/2010EP2155906A1 Method of determining the time to progression of non small cell lung cancer after chemotherapy based on thioredoxin expression
02/24/2010EP2155905A1 Methods for utilizing esr copy number changes in breast cancer treatments and prognoses
02/24/2010EP2155904A2 Methods and compositions for diagnosing osteoarthritis in a feline
02/24/2010EP2155903A2 Allelic polymorphism associated with diabetes
02/24/2010EP2155902A1 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
02/24/2010EP2155901A1 Detection of esr1 amplification in endometrium cancer and ovary cancer
02/24/2010EP2155900A1 Deletion bearing bard1 isoforms and use thereof
02/24/2010EP2155899A2 Methods and computer systems for identifying target-specific sequences for use in nanoreporters
02/24/2010EP2155898A2 Gene expression profiling for identification, monitoring and treatment of ovarian cancer
02/24/2010EP2155897A2 Gene expression profiling for identification, monitoring, and treatment of prostate cancer
02/24/2010EP2155896A1 Method of testing for atp load in commercial laundry and for data tracking the results
02/24/2010EP2155895A2 Methods and uses related to rhbdl4
02/24/2010EP2155893A2 Novel nitroreductase enzymatic substrates
02/24/2010EP2155892A2 Novel peptidase substrates
02/24/2010EP2155891A2 Kinetic determination of peracid and/or peroxide concentrations
02/24/2010EP2155860A1 Multipotent stem cells and uses thereof
02/24/2010EP2155785A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
02/24/2010EP2155772A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
02/24/2010EP2155770A1 A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
02/24/2010EP2155766A1 Redox mediators
02/24/2010EP2155215A1 A gold nanoparticle based protease imaging probes and use thereof
02/24/2010EP1853722B1 Methods and compositions for the detection and analysis of nucleic acids by signal amplification
02/24/2010EP1721008B1 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
02/24/2010EP1721002B1 Method for the identification of sepsis
02/24/2010EP1644732B1 Animal model for the analysis of tumor metastasis
02/24/2010EP1584675B1 Coenzyme-binding glucose dehydrogenase
02/24/2010EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
02/24/2010EP1523573B1 Disease detection by digital protein truncation assays